Please enable JS

DISCOVER

INVESTIGATOR SITE MANAGEMENT

Clinical Trials Mobile Application

We provide innovative digital solutions aiming at facilitating patient recruitment in clinical studies, using current patients’ conditions and powerful build-in algorithms.

Get a demo

Our mission

SOME NUMBERS

Figure: Total R&D/clinical trials pipeline size, by year 2000-2022

They are so many drugs in development that it is extremely challenging to finds the way to one of them, as a patient or as a site, or to secure a high visibility on one of them for a Sponsor.
CT-SCOUT and ToTem4me facilitate the match between the patients and the studies.

50%

OF STUDIES FAIL TO MEET PATIENT RECRUITMENT DEADLINES

However, millions of patients visit clinical sites every day.
CT-SCOUT help investigators identify the ones that could benefit from a clinical study.

80%

OF THE PATIENTS WOULD WELCOME THE OPPORTUNITY TO PARTICIPATE TO A CLINICAL STUDY

Patients have become actors of their treatment conditions.
ToTem4me help them identify potential opportunities through clinical studies.

0.02%

OF THE PATIENTS ARE BEING OFFERED TO PARTICIPATE TO A CLINICAL STUDY

But 80% of patients would accept to participate t a clinical study.
CT-SCOUT contributes to increase the percentage of patients considered for clinical research.

2

WEEKS SET-UP TIME

No more than 2 weeks are required to get CT-SCOUT
or ToTem4me deployed for a clinical study

Our Solutions

We have customised digital solutions for the different contributors to the clinical research efforts.

corner top

CT-SCOUT

The missing link between sponsor & sites

A multi-device application based on a unique algorithmic model to enable all physicians to quickly detect in real-time, the clinical studies running at their sites, for which a patient is potentially eligible according to his/her current health conditions.

Find out more corner bottom
corner top

ToTem4me

The web application for patients

A multi-device application based on a unique algorithmic model, to enable patients, with the direct support of an expert-coordinator, to quickly detect the clinical studies running in their neighborhood, for which they are potentially eligible according to their current health conditions and to inform the corresponding physicians of their potential willingness to participate.

Find out more corner bottom
corner top

eISF

The electronic investigator site file

The eISF, or electronic Investigator Site File, is the digital version of the paper-based investigator site file (ISF). It enables the collection in digital form of essential documents that demonstrate a clinical trial was conducted in accordance with Good Clinical Practice (GCP) guidelines, as well as regulatory and sponsor requirements.

Find out more corner bottom

LATEST NEWSOUR NEWS >

telemedecine technologies news

How Are Healthcare AI Developers Responding to WHO’s New Guidance on LLMs?

January 31, 2024

Med City News This month, the World Health Organization released new guidelines on the ethics and governance of large language models (LLMs) in healthcare. Reactions from the leaders of healthcare AI companies have been mainly positive. In its guidance, WHO outlined five broad applications for LLMS in healthcare: diagnosis and clinical care, administrative tasks, education, […]

READ MORE
telemedecine technologies news

Can Machine Learning be Efficient in Organizing Patient Safety Event Reports?

January 31, 2024

Applied Clinical Trials Online Patient safety event reports (PSEs) play an integral role in hospitals for keeping accurate records of adverse events (AEs). A challenge faced by hospitals is efficiently and accurately classifying these AEs due to the sheer number of reports that are created. A recent study published in JMIR turned to machine learning […]

READ MORE
telemedecine technologies news

Supporting investigators and sites in the evolution to decentralised clinical trials

January 31, 2024

International Biopharma The growing uptake of decentralised clinical trials in recent years reflects several key drivers such as advances in remote monitoring technology and data analytics, the need to access broader, more diverse trial populations, and demand in clinical development for cost efficiencies and meaningful, real world study outcomes. However, we are at a point […]

READ MORE